Concepedia

Marita Zimmermann

MZ

Statistics

Publications

12

Citations

366

H-Index

11

Active since

2017

Affiliations

University of Washington(Current)

Institute for Disease Modeling

Bellevue Hospital Center

Kenyatta National Hospital

Program for Appropriate Technology in Health

Marita Zimmermann is an author at University of Washington specializing in cost-effectiveness analysis, medicine, and economic evaluation.

ORCID

Publications per year

2017–2024

12

Publications

12

Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.

Marita Zimmermann, David M. Rind, Rick Chapman et al. · PubMed · 2018 · 58 citations

, , +17

Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease

Marita Zimmermann, Solomon J. Lubinga, Reiner Banken et al. · Value in Health · 2018 · 56 citations · Full text

, , +12

Disease-Modifying Therapies for Relapsing–Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis

Marita Zimmermann, Elizabeth Brouwer, Jeffrey A. Tice et al. · CNS Drugs · 2018 · 54 citations

, , +11

Household Costs of Diarrhea by Etiology in 7 Countries, The Global Enterics Mulitcenter Study (GEMS)

Marita Zimmermann, Karen L. Kotloff, Dilruba Nasrin et al. · Open Forum Infectious Diseases · 2019 · 38 citations · Full text

, , +17

Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis

Marita Zimmermann, Kurt Frey, Brittany Hagedorn et al. · Vaccine · 2019 · 29 citations · Full text

, , +17

1–5 of 12